Name | Type | Posted | Actions |
|---|---|---|---|
36C24226Q0705.docx | DOCX | Jun 11, 2026 |
6505--FY26QTR4 OPTUM HAZARDOUS DRUG COMPOUNDING, TOMS RIVER, NJ (VA-26-00071687)
Contact and place of performance
Morgan S Weeks
Not specified
This is a notice of intent to award a sole source contract and is not a request for quotes. The Department of Veterans Affairs on behalf of the NJHCS Toms River, NJ Campus intend to award a Firm Fixed Price (FFP), sole source action to a Large Businesses (LB). Name of Contractor: OPTUM PHARMACY 801, INC. Street Address: 23620 N 20TH DRIVE City, State, Zip: PHOENIX, AZ 85085 The prescriptions will be prepared pursuant...
View moreThe Department of Veterans Affairs (VA) intends to award a firm-fixed-price, sole-source contract to Optum Pharmacy 801, Inc., a large business located in Phoenix, Arizona. This procurement, identified by solicitation number 36C24226Q0705, is for hazardous drug compounding services to support the New Jersey Health Care System (NJHCS) Toms River, New Jersey campus. The requirement involves the preparation of chemotherapy prescriptions according to regulatory guidelines, ensuring compatibility with Equishield closed-system transfer devices and VA-preferred administration tubing. The contractor is responsible for maintaining USP 797, USP 800, and FDA standards for aseptic technique, as well as providing specialized shipping and labeling for hazardous materials to ensure delivery by 8:00 a.m. on the scheduled day of treatment.
The scope of services includes the procurement and compounding of specific quantities of various injectable drugs, such as Azacitidine, Bortezomib, Carboplatin, and Cisplatin, along with necessary medical supplies like dextrose solutions and Alaris administration sets. Under the terms of the intended award, prescriptions will be electronically signed by credentialed VA providers and verified by VA pharmacists before being faxed to the contractor. The notice specifies that gray market items are prohibited and all products must be sourced through authorized distribution channels.
This action is classified under NAICS 325412 Pharmaceutical Preparation Manufacturing and PSC 6505 Drugs and Biologicals. While this special notice is not a request for competitive quotes, the government will consider capability statements from responsible sources received by 10:00 a.m. Eastern Standard Time on June 17, 2026. Submissions must demonstrate the ability to meet specific shipping, delivery, and pharmacist verification requirements. Morgan S. Weeks is the designated Contracting Officer for this notice, which was published on June 11, 2026, and includes one attached document.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.